Oxford Asset Management’s DexCom DXCM Stock Holding History

Oxford Asset Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,589	Closed	-$450K	–	599
2025 Q1	$450K	Buy	+6,589	New	+$538K	0.21%	155
2024 Q4	–	Sell	-3,418	Closed	-$229K	–	495
2024 Q3	$229K	Buy	3,418 +1,291	+61%	+$106K	0.19%	217
2024 Q2	$241K	Buy	+2,127	New	+$269K	0.23%	175
2019 Q2	–	Sell	-48,696	Closed	-$1.45M	–	1767
2019 Q1	$1.45M	Buy	48,696 +13,100	+37%	+$460K	0.03%	752
2018 Q4	$1.07M	Buy	+35,596	New	+$1.13M	0.03%	834
2018 Q3	–	Sell	-43,392	Closed	-$1.03M	–	1736
2018 Q2	$1.03M	Buy	+43,392	New	+$920K	0.02%	1028
2013 Q3	–	Sell	-226,564	Closed	-$1.27M	–	821
2013 Q2	$1.27M	Buy	+226,564	New	+$1.09M	0.03%	557

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Oxford Asset Management's DXCM Position: Q2 2025 in Review

Oxford Asset Management sold out of DexCom (DXCM) in Q2 2025, closing a stake of 6,589 shares — an estimated $450K sold.

Oxford Asset Management first reported a position in DXCM in Q2 2013 and held it in 7 quarters. The position peaked at $1.45M in Q1 2019. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

Oxford Asset Management reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
Oxford Asset Management sold 6,589 DexCom shares in Q2 2025, an estimated $450K.
Oxford Asset Management first reported a position in DexCom in Q2 2013 and held it in 7 quarters.
Oxford Asset Management's DexCom position peaked at $1.45M in Q1 2019.
939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Oxford Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.